What are Biomarker Tests for Lung Cancer

What is a “biomarker”?

A biomarker is a substance or a change that can be measured in tissue, blood, or other bodily fluids, and that may signal an abnormal bodily process and/or disease. In cancer, biomarkers may be specific genetic abnormalities that may be identified as the “driver” that is causing the cancer to grow and spread. “Molecular marker,” or “genotype,” are other terms that may be used to describe biomarkers.1,2

Common Biomarkers

Learn more about biomarker testing in NSCLC:

Questions for your healthcare providers

Doctors and other healthcare professionals can provide valuable information if biomarker testing is appropriate for your particular disease. To help you with this conversation, a list of questions are provided below. Consider adding your own personalized questions based on your circumstances.

Learn more about lung cancer

  1. NCI Dictionary of Cancer Terms. National Cancer Institute. Accessed November 11, 2024. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker
  2. Biomarker Tests. LUNGevity Foundation. Updated February 9, 2024. Accessed November 11, 2024. https://www.lungevity.org/for-patients-caregivers/navigating-your-diagnosis/biomarker-testing
  3. Pennell NA, Arcila ME, Gandara DR, West H. Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices. American Society of Clinical Oncology Educational Book American Society of Clinical Oncology Annual Meeting. 2019;39:531-542. doi: https://doi.org/10.1200/EDBK_237863